Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: milestone / Re: lambertslunatics, "mismanagement"?
8
Oct 07, 2009 01:40AM
6
Oct 07, 2009 02:56AM

For example, were there no companies out there that were ALREADY PROFIT generating that could have been aquired for the money issued in dividends?

As you are very good with numbers, what percentage of PTSC did S&L own at the time of the "cash return"?

If you were S&L, given your contractual strength, how much would you have wanted to surrender the convertibles?

Was it a bad decision to remove the S&L overhang?

If S&L still held those convertibles today, what price now to buy them out?

(Without knowing the full details, it is impossible to know if S&L were the only financiers willing to provide PTSC with funding, but you can be sure that a company with growing debts and little revenues would have a very difficult time obtaining funding from alternative sources)

Is PDSG a good investment? I believe that it is. If in 18 months time it proves not to be, wouldn't it be wonderful to then berate the BoD for such a bad decision based on hindsight?

I'm very pleased that the USPTO doesn't use the current understanding of microprocessors on patents filed 20 years ago but adheres to what was expected to be known at that time.

.

.

Be well

5
Oct 07, 2009 10:58PM
Share
New Message
Please login to post a reply